Breaking News

SGS To Open New Lab in France

Adds services for biopharmaceutical analysis

SGS Life Science Services is opening a new 2,000-m2facility in Villeneuve la Garenne, France, replacing an existing lab in Clichy, and increasing Quality Control service throughput and support for R&D. The new lab will be completed in 2Q15.
 
The services currently offered at Clichy, including analytical chemistry, microbiological analysis, stability studies and method development services, will be transferred to the new site, along with additional services for biopharmaceutical analysis, including amino acid analysis and mycoplasma testing. The company is also investing in contained hoods to safely handle biologics, as well as walk-in stability testing chambers for small molecules. The site will be accredited to comply with cGMP regulations.
 
“This investment is a significant step for SGS and its positioning within France, one of the three largest bio/pharmaceutical markets in Europe,” said Paul Beyou, director of Life Science Services, Clichy, “We see the site as being an important strategic tool to keep in step with the small molecule quality control market and begin to address the biologics pipeline within the country, underlining SGS’s ability to evolve along with the needs of our customers.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters